Valuation (71%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 14.68 | N/A |
| PEG Ratio (TTM) | 5.69 | N/A |
| P/S Ratio (TTM) | 0.36 | N/A |
| P/B Ratio (TTM) | 1.25 | N/A |
| P/FCF Ratio (TTM) | 3.62 | N/A |
| Price to 5YR AVG Earnings Ratio | 27.09 | N/A |
| Price to 5YR AVG FCF Ratio | 10.45 | N/A |
Profitability (35%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 4.40% | N/A |
| ROE (TTM) | 8.40% | N/A |
| Net Profit Margin (TTM) | 2.49% | N/A |
| ROIC 5YR AVG | 10.01% | N/A |
Growth (52%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 21.42% | 4.37% | 0.45% |
| Revenue | -2.72% | -1.97% | -2.51% |
| Net Income | 20.59% | 5.12% | 0.46% |
| Cash Flow | 9.25% | 236.06% | 383.69% |
Health (82%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.03 | N/A |
| Quick Ratio (TTM) | 1.27 | N/A |
| D/E Ratio (TTM) | 0.16 | N/A |
| Interest Coverage (TTM) | 9.24 | N/A |
| Piotroski F-Score | 7 | N/A |
| Altman Z-Score | 4.03 | N/A |
| LTL to 5YR AVG FCF | 1.31 | N/A |
| Shares Outstanding Growth 5YR AVG | -0.61% | N/A |